Chair(s)
Lectures of the session
14:18
Prabotulinumtoxin longer duration formulation first interim analysis (Evolus)
14:26
DaxibotulinumtoxinA for injection: the new FDA-approved long lasting botulinum toxin formulation (Revance)
14:57
RelabotulinumtoxinA: proprietary strain and liquid manufacturing process for a novel long-lasting neuromodulator (Galderma)
15:30